Tissue Diagnostic Market - Forecasts from 2016 to 2021
Tissue Diagnostic Market is expected to grow at a CAGR of 11.49% to reach a global market size of $5.105 billion by the end of 2021, exhibiting a lucrative growth potential. Factors driving the market growth of tissue diagnostic industry include high growth potential in emerging economies and rise in a number of cancer cases across the world. Tissue diagnostics is used to screen, diagnose and monitor the response of cancer patients to surgery. Technologies like ISH (In Situ Hybridization), IHC (Immunohistochemistry), digital pathology, workflow and special training are increasingly being used for tissue diagnostic processes. Other factors contributing to the market growth are growing investments towards healthcare, rising incidences of chronic diseases among aging population and burgeoning demand for personalized medicine. The market growth is also being triggered by the demand for accurate diagnostic technologies. The market is also facing various challenges on account of the high degree of consolidation in the industry, stringent regulatory requirements among others.
This report provides a comprehensive analysis of the Tissue Diagnostic Market. The market size and forecast of the global, regional and various segments has been provided in US$ billion.
Under market dynamics section, different drivers, restraints, current trends and opportunities which exist in the market have been discussed with a detailed analysis regarding the same. Market analysis has been provided with the help of Porter’s Five Forces model. The other major sub-sections under this section are supplier outlook, industry outlook, industry lifecycle analysis, and value chain.
Scenario analysis has also been provided considering the different factors affecting the Tissue Diagnostic Market. Under this section, different scenarios like industry regulations and economic factors have been considered to provide market trends over the forecast period.
The report is a 360˚ view of the market by giving details about the key market players and new market entrants. The opportunities which exist in different regions has also been covered by the wide-ranging market segmentation and forecast for Americas, Europe Middle East and Africa and Asia Pacific regions.
Competition analysis section lists vendor market share, recent investments by some of the major players, deals and strategies adopted by them to increase their visibility in the market.
This report provides a comprehensive analysis of the Tissue Diagnostic Market. The market size and forecast of the global, regional and various segments has been provided in US$ billion.
Under market dynamics section, different drivers, restraints, current trends and opportunities which exist in the market have been discussed with a detailed analysis regarding the same. Market analysis has been provided with the help of Porter’s Five Forces model. The other major sub-sections under this section are supplier outlook, industry outlook, industry lifecycle analysis, and value chain.
Scenario analysis has also been provided considering the different factors affecting the Tissue Diagnostic Market. Under this section, different scenarios like industry regulations and economic factors have been considered to provide market trends over the forecast period.
The report is a 360˚ view of the market by giving details about the key market players and new market entrants. The opportunities which exist in different regions has also been covered by the wide-ranging market segmentation and forecast for Americas, Europe Middle East and Africa and Asia Pacific regions.
Competition analysis section lists vendor market share, recent investments by some of the major players, deals and strategies adopted by them to increase their visibility in the market.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
5. TISSUE DIAGNOSTIC MARKET FORECAST BY PRODUCT (US$ BILLION)
5.1. Instruments
5.1.1. Scanners
5.1.2. Thermometers
5.1.3. Tissue-Processing Systems
5.1.4. Other
5.2. Consumables
5.2.1. Reagents
5.2.2. Others
6. TISSUE DIAGNOSTIC MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
6.1. ISH
6.2. IHC
6.3. Digital Pathology and workflow management
6.4. Special Staining
7. TISSUE DIAGNOSTIC MARKET FORECAST BY END USER (US$ BILLION)
7.1. Hospitals
7.2. Laboratories
7.3. Pharmaceutical Enterprises
7.4. Research Organizations
7.5. Others
8. TISSUE DIAGNOSTIC MARKET FORECAST BY DISEASE (US$ BILLION)
8.1. Breast Cancer
8.2. Gastric Cancer
8.3. Prostate Cancer
8.4. Lymphoma
8.5. Non-Small Cell Lung Cancer
8.6. Other Diseases
9. TISSUE DIAGNOSTIC MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
9.1. Americas
9.2. Europe Middle East and Africa
9.3. Asia Pacific
10. COMPETITIVE INTELLIGENCE
10.1. Market Share of Key Players
10.2. Investment Analysis
10.3. Recent Deals
10.4. Strategies of Key Players
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Bio SB
11.3. BioGenex
11.4. Agilent Technologies
11.5. Cell Signaling Technology
11.6. Sakura Finetek Japan
11.7. Hoffmann-La Roche Ltd
11.8. Danaher Corporation
11.9. Sigma-Aldrich Corporation
11.10. Thermo Fisher Scientific
11.11. Johnson & Johnson
11.12. Alere Inc.
11.13. Siemens Healthcare
11.14. GE Healthcare
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
5. TISSUE DIAGNOSTIC MARKET FORECAST BY PRODUCT (US$ BILLION)
5.1. Instruments
5.1.1. Scanners
5.1.2. Thermometers
5.1.3. Tissue-Processing Systems
5.1.4. Other
5.2. Consumables
5.2.1. Reagents
5.2.2. Others
6. TISSUE DIAGNOSTIC MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
6.1. ISH
6.2. IHC
6.3. Digital Pathology and workflow management
6.4. Special Staining
7. TISSUE DIAGNOSTIC MARKET FORECAST BY END USER (US$ BILLION)
7.1. Hospitals
7.2. Laboratories
7.3. Pharmaceutical Enterprises
7.4. Research Organizations
7.5. Others
8. TISSUE DIAGNOSTIC MARKET FORECAST BY DISEASE (US$ BILLION)
8.1. Breast Cancer
8.2. Gastric Cancer
8.3. Prostate Cancer
8.4. Lymphoma
8.5. Non-Small Cell Lung Cancer
8.6. Other Diseases
9. TISSUE DIAGNOSTIC MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
9.1. Americas
9.2. Europe Middle East and Africa
9.3. Asia Pacific
10. COMPETITIVE INTELLIGENCE
10.1. Market Share of Key Players
10.2. Investment Analysis
10.3. Recent Deals
10.4. Strategies of Key Players
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Bio SB
11.3. BioGenex
11.4. Agilent Technologies
11.5. Cell Signaling Technology
11.6. Sakura Finetek Japan
11.7. Hoffmann-La Roche Ltd
11.8. Danaher Corporation
11.9. Sigma-Aldrich Corporation
11.10. Thermo Fisher Scientific
11.11. Johnson & Johnson
11.12. Alere Inc.
11.13. Siemens Healthcare
11.14. GE Healthcare
